NASDAQ:ABVC - Nasdaq - US00091F3047 - Common Stock - Currency: USD
The trading volume of these stocks is deviating from the norm in today's session.
FREMONT, Calif., Dec. 11, 2024 (GLOBE NEWSWIRE) -- ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company advancing therapeutic...
ABVC BioPharma Achieved its First Operational Profit, with a 102% Improvement over the Third Quarter of Last Year.Incremental Payments Received based on...
FREMONT, Calif., Oct. 22, 2024 (GLOBE NEWSWIRE) -- ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company focused on innovative...
• Executed Global Licensing Agreements that could provide up to $292 million in income • Received Cash Milestone Incomes of $116,000 • Achieved...
ABVC BioPharma just reported results for the second quarter of 2024.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips ABVC BioPharma (NASDAQ:ABVC) just reported results for the second quarter of 20...
ABVC BioPharma just reported results for the first quarter of 2024.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips ABVC BioPharma (NASDAQ:ABVC) just reported results for the first quarter of 202...
/PRNewswire/ -- USA News Group – Hope is rising in the fight against one of the deadliest cancers in the world, as a new study recently claimed that a blood...